In a Phase I clinical trial, 10 patients with low-grade B-cell lymphoma were treated by a single locoregional injection of CD3xCD19 bispecific antibodies. Costimulatory signaling, which is required for the optimal activation of resting T cells, was provided by the simultaneous administration o...
Described is the therapy-related AML (acute myelogenetic leukemia)/MDS (myelo-dysplasia syndrome), which is manifested after various treatments of low-grade B-cell lymphoma and has strongly attracted attention because of the markedly improved prognosis due to recent advantages of the therapy for the...
A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. We studied the morphologic, immunologic, and clinical features of 31 cases of malignant lymphoma involving the breast. Primary breast lymphoma occurred in ... AR Mattia,JA Ferry,NL Harris - 《...
maintenance therapy with rituximab provided no significant benefit in those who received initial therapy with R-CHOP for DLBCL.14 Although the addition of rituximab to CHOP has improved the cure rates for patients with DLBCL, Table 1 Treatment of diffuse large B-cell lymphoma Trial Treatment Follow...
maintenance therapy with rituximab provided no significant benefit in those who received initial therapy with R-CHOP for DLBCL.14 Although the addition of rituximab to CHOP has improved the cure rates for patients with DLBCL, Table 1 Treatment of diffuse large B-cell lymphoma Trial Treatment Follow...
Treatment recommendations for patients with diffuse large B-cell lymphoma (DLBCL) begin with evaluating the extent of the disease, performance status of the patient, and histologic subtypes. Treatment of localized and advanced disease varies considerably. Below is a general treatment algorithm for DLBCL...
High-grade B-cell lymphomas (HGBLs) represent a spectrum of different diseases. In 2016, the World Health Organization (WHO) revised their classification of lymphoid neoplasms to account for the major advances in lymphoma biology since 2008.1,2 This revision emphasizes molecular features of clinical...
Your doctor can help you find the right treatment for your type and stage of the illness. Lymphoma is different from leukemia. Each of these cancers starts in a different type of cell. Lymphoma starts in infection-fighting lymphocytes. Leukemia starts in blood-forming cells inside the bone ...
It is of obvious importance for future therapeutic applications of anti-idiotype antibodies to establish the nature of the tumor stem cell in B cell lymphoma. ACKNOWLEDGMENT We wish to thank Professor Dr Philip Riimke and Dr Jan E. de Vries for their stimulating interest, Johan Sein, Trees ...
The main treatments for Hodgkin lymphoma are: Chemotherapy Radiation therapy Immunotherapy If these treatments don't work, you might have astem celltransplant. First, you'll get very high doses of chemotherapy. This treatment kills cancer cells but also destroys stem cells in your bone marrow that...